Building block | Measles study | New vaccine study | Polio study |
---|---|---|---|
Service delivery | Do measles campaigns affect your capacity to reach remote areas for routine outreach services? | Has the number of outreach activities changed because you started offering the new vaccine? | Are routine immunization activities affected during polio campaign days? |
Health workforce | Do measles campaigns take staff away from routine activities? | Did the training focus solely on the new vaccine or did it cover issues relevant for other vaccines or health services too? | Are health workers’ motivation levels the same as before polio campaigns began? |
Health information system | Was there any change in the processes for identifying high risk groups and their vaccination coverage rates? | Have immunisation documents been reprinted to include the new vaccine? If yes, has this changed the time required and data completeness? | Has the surveillance system changed as a result of polio? |
Medical products, vaccines and technologies | Have measles campaigns lead to additional infrastructure, such as waste management equipment? | Has the cold chain capacity related to the new vaccine had any impact for products other than vaccines, such as ARVs? | Have there been any changes in the cold chain infrastructure over the last 10–15 years? Are any of these changes a result of polio? |
Financing and sustainability | Have donor funds been earmarked to measles campaigns? | Has funding requirements for the new vaccine affected the level of funding for other routine health related activities? | Is funding for polio separate from other health programs? |
Leadership/governance | Do you think measles campaigns tend to strengthen or weaken policy processes? | Did the planning for the new vaccine have any effect on planning activities of other health services? | In the past, have government officials given a high level of attention to routine immunization activities? Has this changed as a result of polio? |